Disc Medicine, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Disc Medicine, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2022 to Q3 2024.
  • Disc Medicine, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $6.37M, a 31.2% increase year-over-year.
  • Disc Medicine, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $21.6M, a 74.3% increase year-over-year.
  • Disc Medicine, Inc. annual Nonoperating Income (Expense) for 2023 was $14.8M, a 2183% increase from 2022.
  • Disc Medicine, Inc. annual Nonoperating Income (Expense) for 2022 was $648K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $21.6M $6.37M +$1.52M +31.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $20.1M $4.56M +$3.16M +225% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $16.9M $4.52M +$2.15M +90.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $14.8M $6.17M +$2.39M +63.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $12.4M $4.86M +$10.5M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $1.88M $1.41M -$1.03M -42.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $2.91M $2.37M +$2.26M +2112% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $648K $3.78M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$5.67M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $2.44M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $107K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.